Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcript

SA Transcripts 161.55K Followers Follow Cytek Biosciences, Inc. ( CTKB ) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDT Company Participants Mark Meehan Wenbin Jiang - President, CEO & Chairman of the Board William McCombe - Chief Financial Officer Conference Call Participants Brendan Smith - TD Cowen, Research Division Skye Gilbert - Piper Sandler & Co., Research Division Jason Lai - Morgan Stanley, Research Division Harrison Parsons - Stephens Inc., Research Division Presentation Operator Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today. At this time, I would like to welcome everyone to the Cytek Biosciences second quarter 2026 earnings conference call. [Operator Instructions] I would now like to turn the call over to Mark Meehan. Please go ahead. Mark Meehan Thank you, operator. Joining me today from Cytek are Wenbin Jiang, CEO, and Bill McCombe, CFO. Earlier today, Cytek Biosciences released financial results for the second quarter ended June 30, 2026. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an email to [email protected]. A copy of the news release is also available on the Investor Relations section of Cytek's website at investors.cytekbio.com. Please note that we will be referencing a slide presentation during the call today that has been posted to the investor section of our corporate website. As a reminder, on slide 2, we will make statements during this call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding Cytek's business plans, strategies, opportunities, and financial projections. These statements are based on the company's current expectations and inherently involve significant risks and uncertainties that could cause actual results or events to materially differ from those anticipated in these statements. Additional information regarding these risks and uncertainties